Archives for 13 July 2006
New Drug To Fight Fistulas…
“Ocera Therapeutics specializes in the development and commercialization of new drugs for gastrointestinal and liver diseases.
The company’s current product, AST-120, is a new treatment for use in fighting the formation of fistulas in Crohn’s disease, a form of inflammatory bowel syndrome that afflicts more than 500,000 people in this country. Fistulas are abnormal passages that […]
